IMRX
USDImmuneering Corporation Class A Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$6.210
Máximo
$6.730
Mínimo
$6.150
Volumen
0.05M
Fundamentos de la Empresa
Capitalización de Mercado
403.5M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
1.87M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
- New case studies on first-line pancreatic cancer patients treated with atebimetinib in combination with FOLFIRINOX to be shared by trial investigators – - Conference call scheduled for Wednesday, November 12, 2025, at
Leerink Partners Initiates Coverage On Immuneering with Outperform Rating, Announces Price Target of $15
Leerink Partners analyst Andrew Berens initiates coverage on Immuneering with a Outperform rating and announces Price Target of $15.
Acciones Relacionadas
IRAA
Iris Acquisition Corp
PSN
Parsons Corporation
ABEV
Ambev S.A. American Depositary Shares (Each representing 1 Common Share)
ESQ
Esquire Financial Holdings Inc.
VKTX
Viking Therapeutics Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.